Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Twenty participants, age 18 or older, who meet Diagnostic and Statistical Manual of Mental
Disorders (DSM-5) criteria for moderate to severe Alcohol Use Disorder will be randomized to
open-label psilocybin (25 mg) therapy with the Visual Healing Set and Setting platform (N=10)
versus psilocybin (25 mg) with a standard Set and Setting platform (N=10). The purpose of
this study is to evaluate the feasibility, safety, and tolerability of adding Visual Healing,
a nature-themed virtual immersive program, to psilocybin-assisted therapy among participants
with alcohol use disorder.